Nature's therapy for COVID-19: Targeting the vital non-structural proteins (NSP) from SARS-CoV-2 with phytochemicals from Indian medicinal plants [0.03%]
靶向印度草药中的非结构蛋白(NSPs):植物化学疗法对抗COVID-19
Pratap Kumar Parida,Dipak Paul,Debamitra Chakravorty
Pratap Kumar Parida
Background: Containing COVID-19 is still a global challenge. It has affected the "normal" world by targeting its economy and health sector. The effect is shifting of focus of research from life threatening diseases like c...
SARS-CoV-2 spike protein-, main protease- and papain-like-protease-targeting peptides from seed proteins following gastrointestinal digestion: An in silico study [0.03%]
基于种子蛋白的肠道消化模拟研究：一种针对SARS-CoV-2刺突、主要蛋白酶和类番木瓜蛋白酶肽的体内研究
Fai-Chu Wong,Joe-Hui Ong,Tsun-Thai Chai
Fai-Chu Wong
Background: The anti-COVID-19 potential of phytochemicals was investigated in numerous studies, but efficacy of peptides released by seed proteins upon gastrointestinal (GI) digestion is underexplored. ...
Computational and network pharmacology studies of Phyllanthus emblica to tackle SARS-CoV-2 [0.03%]
计算和网络药理学研究青皮竹叶藤以应对SARS-CoV-2
Rupesh V Chikhale,Saurabh K Sinha,Pukar Khanal et al.
Rupesh V Chikhale et al.
Background: Since December 2019, SARS-CoV-2 had been a significant threat globally, which has accounted for about two million deaths. Several types of research are undergoing and have reported the significant role of repu...
The potential of glycyrrhizin and licorice extract in combating COVID-19 and associated conditions [0.03%]
甘草甜素和甘草提取物在抗击新冠肺炎及其相关疾病中的潜力
Adel A Gomaa,Yasmin A Abdel-Wadood
Adel A Gomaa
Background: Several recent studies have stated that glycyrrhizin and licorice extract are present in most traditional Chinese medicine formulas used against SARS-CoV-2 in China. Significant data are showing that glycyrrhi...
Insights into forsythia honeysuckle (Lianhuaqingwen) capsules: A Chinese herbal medicine repurposed for COVID-19 pandemic [0.03%]
连花清瘟胶囊：一种用于治疗新冠肺炎的中药感冒药配方制剂分析研究进展
Chengyuan Liang,Nan Hui,Yuzhi Liu et al.
Chengyuan Liang et al.
Background: In December 2019, a novel coronavirus, SARS-CoV-2 caused a series of acute atypical respiratory diseases worldwide. However, there is still a lack of drugs with clear curative effects, and the clinical trial r...